The Food and Drug Administration said Monday that it will review data on emergency contraceptive drugs after reports that a similar European drug, Norlevo, changed its labeling due to research that it was ineffective on women who weigh more than 176 pounds, according to Mother Jones.
This is a companion discussion topic for the original entry at https://talkingpointsmemo.com/?p=207527